Sign up to save your podcasts
Or
Share Graham Collins, MBBS, on New Agents, Prognostic Models in Hodgkin Lymphoma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Graham Collins, MBBS, on New Agents, Prognostic Models in Hodgkin Lymphoma
In the latest episode of The HemOnc Pulse, Graham Collins, MBBS, MA, MRCP, FRCPath, DPhil, a lymphoma specialist at Oxford Cancer and Haematology Centre, discusses the findings from the HoLISTIC Consortium, and what he thinks about checkpoint inhibitors upfront in the treatment of Hodgkin lymphoma.
View all episodes
By Rahul Banerjee, MD
4.8
2626 ratings
In the latest episode of The HemOnc Pulse, Graham Collins, MBBS, MA, MRCP, FRCPath, DPhil, a lymphoma specialist at Oxford Cancer and Haematology Centre, discusses the findings from the HoLISTIC Consortium, and what he thinks about checkpoint inhibitors upfront in the treatment of Hodgkin lymphoma.
More shows like The HemOnc Pulse
View all
JAMA Editors' Summary
129 Listeners
Pod Save America
86,615 Listeners
The Daily
111,785 Listeners
The Ezra Klein Show
15,237 Listeners
WolverHeme Happy Hour
29 Listeners